We are live on ! Find out more
TAM

Tocqueville Asset Management Portfolio holdings

AUM $7.56B
1-Year Est. Return 44.87%
This Fund
S&P 500
This Quarter Est. Return
+2.11%
1 Year Est. Return
+44.87%
3 Year Est. Return
+121.98%
5 Year Est. Return
+153.06%
10 Year Est. Return
+501.33%
AUM
$6.74B
AUM Growth
-$112M
Cap. Flow
-$86.3M
Cap. Flow %
-1.28%
Top 10 Hldgs %
24.3%
Holding
603
New
23
Increased
162
Reduced
280
Closed
56

Top Buys

Rank Stock Value
1
GPC icon
Genuine Parts
GPC
+$60.9M
2
EXE
Expand Energy Corp
EXE
+$33.9M
3
DIS icon
Walt Disney
DIS
+$33.2M
4
SBUX icon
Starbucks
SBUX
+$32.7M
5
NFLX icon
Netflix
NFLX
+$22.8M

Sector Composition

Rank Sector Weight
1 Technology 19.21%
2 Industrials 12.78%
3 Healthcare 10.72%
4 Financials 10.45%
5 Consumer Discretionary 10.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNPS icon
526
Synopsys
SNPS
$88.3B
$214K ﹤0.01%
540
BRO icon
527
Brown & Brown
BRO
$24B
$209K ﹤0.01%
+3,200
New +$231K
M icon
528
Macy's
M
$5.89B
$207K ﹤0.01%
+11,420
New +$231K
VLTO icon
529
Veralto
VLTO
$24B
$204K ﹤0.01%
2,309
-381
-14% -$36.2K
DH icon
530
Definitive Healthcare
DH
$85.6M
$203K ﹤0.01%
165,000
VTR icon
531
Ventas
VTR
$47.4B
$201K ﹤0.01%
2,463
-8,727
-78% -$714K
FARM
532
DELISTED
Farmer Brothers
FARM
$197K ﹤0.01%
155,000
-48,000
-24% -$70.2K
MUFG icon
533
Mitsubishi UFJ Financial
MUFG
$252B
$176K ﹤0.01%
10,392
-172
-2% -$3.06K
PUMP icon
534
ProPetro Holding
PUMP
$1.37B
$166K ﹤0.01%
+11,500
New +$137K
CGTX icon
535
Cognition Therapeutics
CGTX
$101M
$148K ﹤0.01%
195,000
+2,500
+1% +$2.91K
S icon
536
SentinelOne
S
$7.84B
$129K ﹤0.01%
10,000
-71,430
-88% -$992K
ONCY
537
Oncolytics Biotech
ONCY
$109M
$126K ﹤0.01%
149,000
+77,000
+107% +$76.6K
AAPL icon
538
PUT
Apple
AAPL
$4.58T
$102K ﹤0.01%
400
MA icon
539
PUT
Mastercard
MA
$518B
$99.9K ﹤0.01%
200
ASPI icon
540
ASP Isotopes
ASPI
$615M
$88.4K ﹤0.01%
20,000
+3,000
+18% +$17.7K
PBYI icon
541
Puma Biotechnology
PBYI
$477M
$82.8K ﹤0.01%
+12,960
New +$83.6K
IONS icon
542
CALL
Ionis Pharmaceuticals
IONS
$10.4B
$75.1K ﹤0.01%
1,000
BBIO icon
543
CALL
BridgeBio Pharma
BBIO
$15.4B
$74.3K ﹤0.01%
1,000
BBDO icon
544
Banco Bradesco
BBDO
$32.8B
$71.7K ﹤0.01%
21,797
+8,776
+67% +$29.6K
DMAC icon
545
DiaMedica Therapeutics
DMAC
$365M
$71.1K ﹤0.01%
+10,500
New +$83.2K
UFI icon
546
UNIFI
UFI
$140M
$41.6K ﹤0.01%
11,666
ZVIA icon
547
Zevia
ZVIA
$102M
$19K ﹤0.01%
16,228
ANET icon
548
Arista Networks
ANET
$252B
-2,033
Closed -$266K
ARCC icon
549
Ares Capital
ARCC
$14.3B
-46,468
Closed -$940K
ARCT icon
550
Arcturus Therapeutics
ARCT
$467M
-13,600
Closed -$83.4K

Similar funds

Tocqueville Asset Management's Q1 2026 Portfolio in Review

As of Q1 2026, Tocqueville Asset Management held 603 positions worth $6.74B, down 1.6% from $6.86B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Tocqueville Asset Management's Q1 2026 filing shows 23 new, 162 increased, 280 reduced and 56 closed positions. Its largest new stake was Pacific North of South EM Equity Active ETF: 150,202 shares worth $5.23M. The largest sale was Regeneron Pharmaceuticals, an estimated $23.8M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Industrials and Healthcare.

  • Tocqueville Asset Management's largest Q1 2026 buy was Pacific North of South EM Equity Active ETF: 150,202 shares worth $5.23M.
  • Tocqueville Asset Management added most to Genuine Parts in Q1 2026, an estimated $60.9M increase.
  • Tocqueville Asset Management's biggest Q1 2026 reduction was Regeneron Pharmaceuticals, cutting an estimated $23.8M.
  • Tocqueville Asset Management fully exited State Street SPDR S&P Regional Banking ETF in Q1 2026, selling an estimated $15.2M.
  • Tocqueville Asset Management's ten largest holdings make up 24% of its $6.74B portfolio in Q1 2026.
  • Tocqueville Asset Management opened 23 new positions and closed 56 in Q1 2026.
  • Tocqueville Asset Management's portfolio value fell 1.6% quarter-over-quarter to $6.74B.

Based on Tocqueville Asset Management's 13F filing for Q1 2026, filed 12 May 2026.